8′-Norvincaleukoblastine,3′,4′-didehydro-4′-deoxy-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:2) (salt);
3′,4′-Didehydro-4′-deoxy-8′-norvincaleukoblastine l-(+)-tartrate (1:2) (salt) 3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine l-tartrate (1:2) (salt) [125317-39-7]
BRIEFING
Vinorelbine Tartrate. This proposal is based on the version of the monograph official as of May 1, 2020. It is proposed to revise the monograph with the following changes:
-
Update the molecular weight and chemical name of Vinorelbine Tartrate in the Chemical Information section.
-
Update the sample preparation procedure for 197K of Identification A to remove the requirement for a toxic solvent.
-
Add 197A to Identification A to allow the flexibility of using either 197A or 197K.
-
Revise the Assay as follows:
-
Add the Run time.
-
Replace the Note and add Table 1 reference to present relative retention times as an aid in peak assignment and update the chemical information of 3,6-Epoxy vinorelbine and Vinorelbine related compound A.
-
Revise the chemical name of 3,6-epoxy vinorelbine to epoxy vinorelbine.
-
Tighten the requirement for the Relative standard deviation from NMT 2.0% to NMT 0.73% based on supporting data and to be consistent with the expectations of a modern chromatographic system.
-
-
In the test for Organic Impurities:
-
Add the Sensitivity solution, revise the Standard solution, and update the Suitability requirements based on supporting data to be consistent with the expectations of modern chromatographic systems.
-
Update the relative retention time of epoxy vinorelbine from 0.8 to 0.81, and chemical information of 3,6-Epoxy vinorelbine and Vinorelbine related compound A in Table 1.
-
Revise Table 2 in the Acceptance criteria to list only the limits for specified impurities, any unspecified impurity, and total impurities.
-
Update the chemical names of impurities in Table 2.
-
In the Acceptance criteria, add a reference to User-Determined Reporting Thresholds 〈477〉 for user flexibility. For more information about this change, please see the USP Compendial Notice “New Chapter 〈477〉 User-Determined Reporting Thresholds and Its Implementation in USP–NF Monographs”.
-
-
Replace the tests for Clarity of Solution and Color of Solution with Bacterial Endotoxins Test, Sterility Tests, and a Labeling section to support preparation of sterile drug products and to strengthen the monograph.
-
Update the pH test to provide clarity.
-
Update the chemical information of USP Vinorelbine Related Compound A RS in the USP Reference Standards section.
Additionally, minor editorial changes have been made to update the monograph to current USP style.
(SM3: J. Kilari)
Case ID—SUB-732; SUB-1519
USP REFERENCE STANDARDS FOR PURCHASE
USP Vinorelbine Related Compound A RSUSP Vinorelbine Tartrate RS